About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

RECRUITINGNA

Relation Between Psychoactive Drugs Overdosage and Severity of Falls in Elderly People

Consequence of Plasma Concentrations of Psychoactive Drugs Located Beyond Therapeutic Ranges on Severity of Falls in Patients Over 75 Years Old

NCT05991037•University Hospital, Caen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Fall

Interventions

Blood sampling for psychoactive drugs dosage

Locations

1

France

Locations (1)

Caen University Hospital

Caen, France

Key Dates

Start Date

May 22, 2024

Primary Completion Date

May 30, 2027

Completion Date

May 30, 2028

Last Updated

July 25, 2025

Related Studies

RECRUITINGPhase 3

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

NCT07213804

Ovarian NeoplasmsFallopian Tube Neoplasms+2 more

RECRUITINGPhase 1/2

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Advanced CancerMetastatic Cancer+7 more

RECRUITINGPhase 3

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian Cancer+5 more

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

NCT07112573

Falls (Accidents) in Old AgePsychotropic Drugs

Patient Perspectives of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

NCT05846685

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

NCT06932081

Adult Congenital Heart DiseaseCongenital Heart Disease+6 more

View all related studies

Contacts

Véronique Lelong-Boulouard, PhD

CONTACT

0231063341 lelongboulouard-v@chu-caen.fr

Cédric Villain, PhD

CONTACT

villain-c@chu-acen.fr

Sponsors

Lead Sponsor

University Hospital, Caen

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions